Condition: Intubation Complication · Eschar · Sponsor: Hopital Foch
The aim of this study is to assess the benefits of using the Anchorfast device in reducing complications associated with intubation tube fixation, in terms of the rate of pressure ulcer development, the rate of intubation tube mobilization and the rate of VAP occurrence. If the hypothesis is confirmed, this project would enable the caregivers to optimize the current practice in the interests of both patients and caregivers. That's why the investigators have designed a real-life study, and will also be looking at the effect of care load on and caregiver satisfaction.
This description comes directly from the study's public registry record.
Marisa LAGOA PINTO · 00 33 1 46 25 36 35 · m.lagoa-pinto@hopital-foch.com
Marjolaine NGOLLO, PhD · +33 146 25 37 49 · drci-promotion@hopital-foch.com
Always discuss trial participation with your own doctor first.
| Hôpital Foch | Suresnes, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06533436